Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non–Small-Cell Lung Cancer

Overview of attention for article published in Clinical Lung Cancer, September 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 29 X users

wikipedia: 1 Wikipedia page

Readers on

mendeley: 44 Mendeley

So far, Altmetric has seen 30 X posts from 29 X users, with an upper bound of 119,684 followers.

And please remember: don’t use immunotherapy!! https://t.co/4pdo0fOrc2

RT @4baseCare: Therapy with immune checkpoint inhibitors (ICIs) is a treatment option in NSCLC but, the efficacy of ICI is inconclusive in…

Some alterations are predictors of some other treatment regimes.

RT @4baseCare: Therapy with immune checkpoint inhibitors (ICIs) is a treatment option in NSCLC but, the efficacy of ICI is inconclusive in…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 26 additional X posts.